ArticleJournal of Ayurveda and integrative medicine
Tapentadol and Zolpidem addiction management with Ayurvedic intervention: A case report.
Article in Journal of Ayurveda and integrative medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Opioids pose significant challenges worldwide. Tapentadol's unrestrained availability has raised concerns, as it is developing as an alternative for illicit pharmaceutical opioids. A case of 31-year-old patient complaining of anxiousness, profuse perspiration, body ache, lacrimation, restlessness, sleeplessness, and loose stools with history of Tapentadol and zolpidem abuse showed in the OPD on Oct 31, 2023. The patient's Clinical opiate withdrawal scale (COWS) evaluated withdrawal symptoms of the as moderate (score 28) and the Insomnia Severity Index (ISI) showed the severe insomnia (score 25). Patient was prescribed with tapering dose of Sameergajakesari Rasa (375, 250, 125mg), Vishatindukadi Vati 250mg, Combination of Sitopaladi Churna 3g + Lakshmivilas Rasa 250mg + Tankan Bhasma 250 mg, over 3 weeks, Combination of Vaatvidhwansank Ras 250mg + Godanti Bhasma 250mg + Tryodshang Gugglu 500mg for first 2 weeks, Ksheerpaka of Ashwagandha Churna 3g + Shatavari Churna 2g + Gokshur Churna 1g and Brahmarasayan 5g for third week. Externally Dashmoola Tail Sarvanga Abhyanga, Sarvanga Swedana, Shirodhara with Til Taila and Brahmi Tail, Pranayama, Yoga and counselling. The total COWS score decreased from 28 prior to treatment to 2 after three weeks of treatment. Similarly, ISI score decreased from 25 to zero after treatment. The patient was treated solely using Ayurvedic treatment, including Satvajaya Chikitsa, and no complications were noticed during the course of treatment. Observations suggested that with the Ayurvedic management, withdrawals and insomnia were completely resolved within three weeks of treatment. The baseline investigations were normal, and the patient continued to practice yoga and counselling during and after therapy, abstaining for 60 days post treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.